Evaluation of Bruton's Tyrosine Kinase (BTK) inhibition with alternative doses of ibrutinib in subjects with Chronic Lymphocytic Leukemia (CLL).
| Publicado en: | Cancer Chemotherapy & Pharmacology Vol. 95; no. 1; pp. 1 - 12 |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
Springer Nature
2/28/2025
|
| Acceso en línea: | Ver este registro en EBSCOhost |